Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.
about
Antidrug Antibodies: B Cell Immunity Against TherapyOccurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort AnalysisThe Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy.Evaluating response to disease-modifying therapy in relapsing multiple sclerosis.Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.Lateral and escalation therapy in relapsing-remitting multiple sclerosis: a comparative study.Drug Efficacy Monitoring in Pharmacotherapy of Multiple Sclerosis With Biological AgentsPractical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases.Prevalence of neutralising antibodies to interferon-beta and clinical response in Chinese patients with relapsing multiple sclerosis.Cross-reactivity of antibodies against interferon beta in multiple sclerosis patients and interference of the JAK-STAT signaling pathway.Neutralizing Antibodies Against Interferon-Beta in Korean Patients with Multiple Sclerosis.
P2860
Q28082303-749E1C33-C87F-418A-A699-60CAD066E0A3Q28553133-F233A17B-0B85-45BF-BF41-097848E19065Q36070808-AB509138-1FDB-4DCA-86E3-A6E1E205F881Q38375605-5EF4C8C0-835C-494E-9527-D3CD802B7E8AQ38802998-260432B3-2AF2-4834-8802-E775F94531FEQ39675286-1238A4B7-F583-466B-B309-9A4BADDF7A54Q41198127-6C263131-C4F7-4FD5-9F03-F0E61BE39596Q42373188-515CC610-F5A3-4FDB-9B54-78B06FC8E306Q42375591-43361C40-4236-4435-B1A8-5F5B27E22411Q47159185-032C0E6C-BFFA-479C-839B-FB784B1AD4B7Q53080613-4865E0DD-29DB-4C4A-AF92-3DB8AFAFC050
P2860
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Guidelines on the clinical use ...... ultiple Sclerosis Study group.
@en
type
label
Guidelines on the clinical use ...... ultiple Sclerosis Study group.
@en
prefLabel
Guidelines on the clinical use ...... ultiple Sclerosis Study group.
@en
P2093
P2860
P50
P1476
Guidelines on the clinical use ...... Multiple Sclerosis Study group
@en
P2093
Antonio Gallo
Carlo Pozzilli
Chiara Mancinelli
Elisabetta Capello
Enrico Montanari
Francesco Patti
Gioachino Tedeschi
Italian Multiple Sclerosis Study group
Lucia Moiola
Luigi Grimaldi
P2860
P2888
P304
P356
10.1007/S10072-013-1616-1
P50
P577
2013-12-29T00:00:00Z